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Abstract
The olfactory mucosa, located in the nasal cavity, is in charge of detecting odours. It is also the only nervous tissue that is exposed to the external
environment and easily accessible in every living individual. As a result, this tissue is unique for anyone aiming to identify molecular anomalies in
the pathological brain or isolate adult stem cells for cell therapy.
Molecular abnormalities in brain diseases are often studied using nervous tissue samples collected post-mortem. However, this material has
numerous limitations. In contrast, the olfactory mucosa is readily accessible and can be biopsied safely without any loss of sense of smell1.
Accordingly, the olfactory mucosa provides an "open window" in the adult human through which one can study developmental (e.g. autism,
schizophrenia)2-4 or neurodegenerative (e.g. Parkinson, Alzheimer) diseases4,5. Olfactory mucosa can be used for either comparative molecular
studies4,6 or in vitro experiments on neurogenesis3,7.
The olfactory epithelium is also a nervous tissue that produces new neurons every day to replace those that are damaged by pollution, bacterial
of viral infections. This permanent neurogenesis is sustained by progenitors but also stem cells residing within both compartments of the mucosa,
namely the neuroepithelium and the underlying lamina propria8-10. We recently developed a method to purify the adult stem cells located in the
lamina propria and, after having demonstrated that they are closely related to bone marrow mesenchymal stem cells (BM-MSC), we named them
olfactory ecto-mesenchymal stem cells (OE-MSC)11
.
Interestingly, when compared to BM-MSCs, OE-MSCs display a high proliferation rate, an elevated clonogenicity and an inclination to differentiate
into neural cells. We took advantage of these characteristics to perform studies dedicated to unveil new candidate genes in schizophrenia and
Parkinson's disease4. We and others have also shown that OE-MSCs are promising candidates for cell therapy, after a spinal cord trauma12,13, a
cochlear damage14 or in an animal models of Parkinson's disease15 or amnesia16.
In this study, we present methods to biopsy olfactory mucosa in rats and humans. After collection, the lamina propria is enzymatically separated
from the epithelium and stem cells are purified using an enzymatic or a non-enzymatic method. Purified olfactory stem cells can then be either
grown in large numbers and banked in liquid nitrogen or induced to form spheres or differentiated into neural cells. These stem cells can also be
used for comparative omics (genomic, transcriptomic, epigenomic, proteomic) studies.
Video Link
The video component of this article can be found at http://www.jove.com/details.php?id=2762
Protocol
1. Collection of Olfactory Mucosa in Rats
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1. Begin by preparing three 35 mm Petri dishes filled with DMEM/HAM F12 culture medium in a clean culture hood.
2. Any method of euthanasia must be approved in advance by the institution's animal care and use committee and carried out by qualified
personnel. After the rat has entered deep anesthesia with sodium pentobarbital or other injectable forms of anesthesia such as
ketamine/xylazine, decapitate and remove the skin. Inhalant anesthetics should be avoided. Adequacy of anesthesia will be assessed by toe
pinch prior to decapitation. Remove the lower jaw with scissors and with the help of a rongeur, eliminate the facial muscles on both sides.
3. Starting from the back of the incisors, remove with a rongeur the bone covering the nasal cavity, one side at a time. The olfactory turbinates
come into sight as orange/brown organs located in the back of the nose.
4. Delicately discard the turbinates with a forceps. Using a 26 gauge needle, isolate the olfactory mucosa lying on the septum by cutting the
tissue along three lines: the arc of the perpendicular plate, the cribriform plate and the ceiling of the nasal cavity.2. Collection of Olfactory Mucosa in Humans
3. Isolation of Olfactory Stem Cells from Human and Rat Mucosa
4. Sphere Formation and Neuronal Differentiation of Olfactory Stem Cells
5. Representative Results:
Nasal human explant-outgrowing stem cells (Figure 2A) are dividing rapidly and confluency can be reached within one to two weeks. One key
feature of stemness, nestin expression, was evaluated (Figure 2B). When grown on poly-L-lysine with a serum-free culture medium
supplemented with EGF (50 ng/ml) and FGF2 (50 ng/ml), olfactory stem cells give rise to spheres (figure 2C). When grown in serum-containing
culture medium newly plated spheres give rise to GFAP-expressing cells (˜50%), tubulin-expressing cells (˜10-15%) and O4-expressing cells
(˜2-5%)9 (Figures 2D-F). However, the fate of the sphere-derived cells can be modified. For example, when grown in a Neurobasal culture
medium supplemented with B27 and glutamate, most of the nasal olfactory stem cells into neuron-like cells expressing β-III tubulin (Figure 2G)
and MAP2 (Figure 2H).
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5. Collect biopsies on both sides and transfer them in a DMEM/HAM F12-filled Petri dish. This procedure should not take longer than 10 minutes
from the onset euthanasia.
6. Now, in order to remove the mucus, transfer the biopsies two times in medium-filled Petri dishes.
1. This procedure should be carried out by an Ear Nose and Throat (ENT) surgeon, in accordance with the relevant local ethical committee(s),
and every outpatient should sign an informed consent form.
2. Using a 0° or 30° rigid endoscope (4 mm diameter), inspect both nasal cavities and assess the putative presence of polyps or any
inflammatory lesion. Choose the best nasal cavity, taking into account the deviation of the septum.
3. Using a cotton applicator, apply a local anesthetic, such as lidocaine with epinephrine, for 10 minutes.
4. With a throughcut ethmoid forceps, collect a two square millimeter biopsy either at the root of the medial aspect of the middle turbinate or on
the septum in the dorsomedial area.
5. The olfactory biopsy is then transferred, using a sterile needle, into a sterile 2 ml tube filled with 1 ml of DMEM/HAM F12. Tip the tube upside
down to make sure that the biopsy is immersed in the culture medium.
6. Insert the tube in a refrigerated container and transport it to the research laboratory. At this stage, the biopsy can be used per se for
comparative molecular studies focused on specific brain diseases or processed for generating stem cells.
1. Wash the biopsies in DMEM/HAM F12. Incubate the biopsies in a Petri dish filled with 1 ml of dispase II solution (2.4 IU/ml), for 1 hour at
37°C.
2. Next, under a dissecting microscope with a diffracted inverted light, the olfactory epithelium is removed from the underlying lamina propria
using a micro spatula.
3. The olfactory epithelium is thinner and looks translucent over a black background compared to the lamina propria which is striped
orange/brown. Over a white background, the epithelium looks gray and the lamina propria, brown.
4. Once purified, transfer the lamina propria into a Petri dish filled with DMEM/HAM F12.
5. If the tissue is from a rodent, then cut the lamina propria into small pieces with two 25 gauge needles. Then, transfer the pieces to a 15 ml
tube filled with 1 ml of collagenase IA.
6. In the tube, using a sterile plastic pipette, dissociate the tissue. Then, incubate the tube for 10 minutes at 37°C.
7. To terminate the dissociation, gently rock the tube and add 9 ml of Ca-free and Mg-free PBS and centrifuge at 200 g for 5 minutes.
8. Resuspend the cell pellet in DMEM/HAM F12 culture medium supplemented with 10% fetal calf serum, antibiotics and plate on plastic culture
dishes.
9. Now, if the tissue is human, then slice the lamina propria into 3 to 4 pieces with a thickness ranging from 200 to 500 μm.
10. Insert each strip into its own 2 cm diameter culture dish and cover the tissue with sterile 1.3 cm diameter glass cover slips.
11. Then, add 500 μl of culture medium (DMEM/HAM F12 supplemented with 10% fetal calf serum and antibiotics) to each culture dish.
12. For either tissue type, renew the culture medium every 2 to 3 days.
13. Five to seven days after, stem cells will begin to invade the culture dish and after two weeks they should be confluent. When confluency is
reached, passage and transfer the cells to culture flasks.
1. To generate stem cell spheres, incubate the flasks for two hours at 37°C with poly-L-lysine. (TEXT: 5 g/cm2).
2. Plate the cells at a density of 16,000 cells per square centimeter in the treated flasks.
3. Every two days, feed the cells with 0.2ml per square centimeter of supplemented medium (DMEM/HAM F12 supplemented with insulin,
transferrin, selenium (ITS-X, 1%), EGF (50 ng/ml) and FGF2 (50 ng/ml)).
4. Two to five days later, collect floating cell spheres and either re-plate or dissociate them before grafting in animal models of cell therapy.
5. To differentiate olfactory stem cells into neuron-like cells, cultivate them for 21 days in Neurobasal medium containing B-27, penicillin,
streptomycin, glutamine and glutamate.
6. Then make medium changes every 3 days. Neuron-like cells should appear after two to three weeks. 
Figure 1. Overall scheme of the experiment. Olfactory mucosa biopsies are excised from rat or human nasal cavity. Explants can be used per se
for comparative molecular studies aiming to identify biomarkers in brain diseases. For isolating olfactory stem cells, the interactions between the
lamina propria and the neuro-epithelium are disrupted with the dispase II enzyme and, after 45 minutes, the epithelium is removed with a
micro-spatula. Rodent olfactory stem cells are further selected by dissociating the lamina propria with collagenase IA. For human tissue, pieces of
olfactory lamina propria are cultured under glass coverslip until outgrowing stem cells invade the whole well. After proliferation, using an
appropriate culture medium, olfactory stem cells can generate spheres or differentiate into neuron-like cells. Olfactory stem cells can be used to i)
repair brain diseases or trauma or ii) identify molecular markers of central nervous system diseases. Illustrations are made with the help of
Servier Medical Art.
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Figure 2. Culture and differentiation of nasal human olfactory stem cells. Human stem cells growing out of the lamina propria explant (A) are
dividing rapidly, when cultivated in a serum-containing medium. Stem cells express the stemness marker nestin (B). When plated on
poly-L-lysine-coated plastic and cultivated in a serum-free culture medium supplemented with EGF and FGF2, olfactory stem cells generate
spheres (C). Sphere-derived cells, when plated in serum-containing culture medium, give rise to GFAP-expressing cells (˜50%),
tubulin-expressing cells (˜10-15%) and O4-expressing cells (˜2-5%)9 (D-F). When grown in a Neurobasal culture medium supplemented with B27
and glutamate, they differentiate into neuron-like cells expressing β-III tubulin (G) and MAP2 (H).
The techniques presented here make the rodent and human olfactory mucosa a useful model for clinical research into the causes of
neurodevelopmental and neurodegenerative diseases as well as a tool for repairing the pathological or traumatized brain. The protocol is
relatively straightforward and can be easily carried out by an experienced cell biologist. The success rate for the biopsy and culture techniques is
high.
Critical steps
Possible modifications
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• For the collection of rodent olfactory mucosa, it is recommended not to exceed a time limit of 10 minutes between euthanasia and the final
excision of the olfactory tissue.
• The dissociation of the rodent olfactory lamina propria is usually achieved after 10 min. incubation in collagenase IA. If not, we recommend to
collect the day after the supernatant in which undissociated bits of lamina propria float, centrifuge it at 200 g and mechanically dissociate the
floating lamina using a Pasteur pipette before replating the cells in a new well. The first well containing the already attached cells is filled with
fresh culture medium.
• For the human lamina propria, which is more compact than the rodent tissue, we do not recommend an enzymatic dissociation. The tissue is
sliced and each explant is inserted between the bottom of the plastic dish and a glass coverslip. Successful cultures include explants whose
thickness range from 200 to 500 μm.
• The current protocol can be slightly modified in order to generate olfactory neurons in vitro. For that purpose, the neuro-epithelium is not
removed and the whole olfactory mucosa is sliced with a McIlwain chopper (200 μm thickness). Each explant is plated in a dish, partially dried
for one hour and then rehydrated with FCS-containing culture medium. During the first days post plating, epithelial and mesenchymal cells
grow out of the explant. Then, neuron progenitors will migrate on the top of this cell layer and differentiate into neurons.
• Purification of olfactory stem cells can be achieved using flow cytometry. Specific surface markers can be retrieved from the list published in
the characterization paper11
.
• For transplantation experiments, it is possible to use a strain of rats whose olfactory stem cells are GFP-positive. This rat strain (Sprague
Dawley, eGFP driven by the PGK promoter) is available at ITERT (Nantes, France). For inserting the GFP gene in human olfactory stem
cells, we use a method based on lentivirus infection.Future applications
Disclosures
No conflicts of interest declared.
Acknowledgements
This work was financially supported by ANR (Agence nationale de la Recherche), AFM (Association Française contre les Myopathies), FEDER in
PACA and IRME (Institut de Recherche sur la Moelle épinière et l'Encéphale). We greatfully thank Marie Pierre Blanchard (Jean Roche Institute)
for her efficient help during time lapse recording.
References
August 2011 |  54  | e2762 | Page 5 of 5
Journal of Visualized Experiments www.jove.com
Copyright © 2011  Creative Commons Attribution License
• This paper is focused on olfactory ecto-mesenchymal stem cells. However, another cell type of interest, the olfactory ensheathing cells, can
be purified from the same tissue. We described a method for their collection and purification1,17 and we used human nasal ensheathing cells
for a phase I/IIa clinical trial in paraplegic patients18.
• As a member of the mesenchymal stem cell superfamily, OE-MSCs are able, under appropriate culture conditions, to differentiate into
adipocytes, osteocytes and myocytes11
.
• We have already used human olfactory biopsies to study cellular and molecular anomalies in patients with autism, bipolar disorder, familial
dysautonomia, Parkinson's disease, Alzheimer's disease and schizophrenia2-7. Theoretically, all brain diseases can be studied using nasal
biopsies or peripheral olfactory stem cells.
• Rodent and human nasal olfactory stem cells have already been grafted in animal models of amnesia, Parkinson's disease, cochlear damage
and spinal cord trauma12-16. It is conceivable to transplant these cells into animal models of Alzheimer's disease, brain ischemia, Multiple
sclerosis.
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